In This Article:
MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., that it will be relying on CSA Coordinated Blanket Order 51-913 for an exemption from the requirements to send proxy-related materials for its upcoming annual general meeting (the “Meeting”) to be held on January 30, 2025, at 11:00 a.m. (Montréal time) (the “Proxy-Related Materials”), due to the current delays and suspension of mail service in Canada as a result of the nationwide strike of the Canadian Union of Postal Workers that commenced on November 15, 2024 (the “Postal Strike”).
Access to Documents
The Proxy-Related Materials are available under the Company’s profile on SEDAR+ at www.sedarplus.ca or on Cannara’s website at www.cannara.ca/investors.
Date and Time of the Meeting
The Meeting will be held a virtual-only format, which will be conducted via live audio webcast and teleconference accessible via the following link:
To join the meeting via teleconference, please dial 1-438-797-4001 (Canada) or 1-650-479-3208 (US) and use meeting code 2636 952 9781 and passcode LOVE2025 (56832025 when dialing from a phone or video system). Shareholders accessing the Meeting via teleconference will not be able to vote or speak at the Meeting. To vote or speak at the Meeting, shareholders will need to join the webcast and utilize the chat function during the Meeting. A moderator will be present to allow shareholders to vote or speak at the Meeting at the appropriate time.
Meeting Matters
In addition to receiving the Corporation’s consolidated financial statements for the fiscal year ended August 31, 2024, and the related auditor’s report, shareholders will be invited to vote on the following items at the meeting:
-
to determine the number of directors and to elect the directors to serve until the Company’s next annual general meeting;
-
to appoint MNP LLP as auditors of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration to be paid to the auditors for the ensuing year;
-
to consider and, if thought fit, to pass an ordinary resolution to approve the Company’s stock option plan, amended, the whole as described in the accompanying management information circular;
-
to consider and, if thought fit, to pass an ordinary resolution to approve the Company’s restricted share unit compensation plan, the whole as described in the accompanying management information circular;
-
to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.